Results 1 to 10 of about 19,047 (182)

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Oncolytic virus therapy for osteosarcoma: mechanisms, opportunities, and challenges. [PDF]

Front Immunol
Wang JW, Ge X, Liu JH, Zhang X.
europepmc   +1 more source

Oncolytic virus and immunogenic cell death in cancer therapy. [PDF]

Tumour Virus Res
Cao G, Ding C, Dai J, Qiu X.
europepmc   +1 more source

Functional analysis and verification of GYG2 in oncolytic virus-infected glioma. [PDF]

BMC Cancer
Dong Y, Wang S, Wang C, Zhou J, Zhang Y, Yin X.   +5 more
europepmc   +1 more source

Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs. [PDF]

Nat Commun
Li J, Chaurasiya S, Sun G, Cui Q, Ye P, Qin Y, Zhou T, Wang X, Fong Y, Maus MV, Shi Y.   +10 more
europepmc   +1 more source

Engagement of the TCR against an oncolytic virus generates a population of effector CAR T cells with potent antitumor activity. [PDF]

Sci Adv
Liseth O, Appleton E, Kendall B, Thompson J, Sangsuwannukul T, Tonne J, Diaz RM, Evgin L, Patrikeev A, Sarbia N, Foo S, Harrington K, Ono M, Melcher A, Vile R.   +14 more
europepmc   +1 more source

Multistage responsive microneedle delivery system loaded oncolytic virus for topical therapy of melanoma. [PDF]

Acta Pharm Sin B
Wang Z, Yan Z, Chen H, Wang Y, Shi Y, Jing Y, Ming R, Liu S, Jin P, Wu G, Huang L.   +10 more
europepmc   +1 more source

Enhancing Oncolytic Virus Therapy with Nanomedicine: A Review of Progress, Challenges, and Future Directions in a New Frontier of Cancer Treatment. [PDF]

Int J Nanomedicine
Qiu J, Liao Y, Kan D, Liao L, Yang K, Hu X, Wang Z, Yu H, Xie F, Liu Z.   +9 more
europepmc   +1 more source

TAMs-mediated resistance to oncolytic virus M1 in solid tumors. [PDF]

J Immunother Cancer
Liang X, Li J, Chen J, Chen C, Li H, Yan C, Guo C, Han Y, Liu W, Sai K, Lin Y, Yan G, Zhu W, Liu Y.   +13 more
europepmc   +1 more source

Combination of Vaccine With IL-12-Armed Oncolytic Virus SKV-012 Synergistically Potentiates Immune Responses in HPV-Associated Malignancies. [PDF]

MedComm (2020)
Yang N, Xu L, Zheng M, Lu H, Chen Y, Zhu Z, Zeng W, Wang Z, Li H, Li J, Jiang Z, Zeng P, Wang G, Xie H, Zhang Z, Yang H, Tong A.   +16 more
europepmc   +1 more source